ÂÜÀòÂÒÂ×

Christina Nalbandian Tachdjian, MPH, is currently the Associate Director of Development Business Operations, Clinical Pricing at Gilead Sciences. Previously, they worked in various roles, including Senior Manager of Business Operations at Nektar Therapeutics and Associate in the Clinical Contracting Group at Amgen. Christina began their career as a Laboratory Associate at City of Hope, contributing to notable research on Herpes Simplex Virus. They hold a Master of Public Health from the University of Southern California and are pursuing a Bachelor's Degree in Molecular Cell Biology with an emphasis in Immunology at the University of California, Berkeley.